@BestinthePNW_ @D28EquityNow @drlucymcbride @kprather88 Same story with the one mab that works, or evoshield for IC, which you hear a lot about. Even transplant patients can't get it unless very highest of the high risk (all transplant patients are high risk).
Big difference between a press release and actual availability.
@BestIn PNW_@D28EquityNow@drlucymcbride@kprather88与一个有效的mab或evoshield for IC的故事相同，你经常听说它。即使是移植患者也不能得到它，除非风险最高（所有移植患者都是高风险的）。
新闻稿和实际可用性之间有很大区别。